Track the Haleon plc share price and the full management transaction log of the company, a listed issuer based in United Kingdom. Shares trade on the UK market, under the authority of RNS (LSE). Market capitalisation: €38.3bn. The latest transaction was filed on 25 May 2026 (Purchase). Among the most active insiders: Tamara Rogers. Every trade is accessible without an account.
163
Insider Decl.
n/a
Thresholds
€1m
113 ops.
Buy Volume
€396,900
17 ops.
Sell Volume
30Σ signal
Buys €1m€396,900 Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 9,760 of 29,057 companies
59.7
score / 100
Value
54
Quality
65
FCF yld5.8%
Earn yld4.4%
EV/EBITDA16.4x
ROE·
Gross mgn64%
Net mgn15%
Debt/EBITDA3.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
72 shares@ £3.56327.1% of flowLondon Stock Exchange (XLON)RNS:5777462-1
25 of 163 declarations
About Haleon plc
Haleon plc is a consumer health company that provides a range of oral health, vitamins, and over-the-counter medicines. It is listed on the London Stock Exchange under the ticker HLN.